NRX Pharmaceuticals (NRXP) Goodwill & Intangibles (2025 - 2026)

NRX Pharmaceuticals (NRXP) has reported Goodwill & Intangibles for 2 consecutive years, with $2.7 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Goodwill & Intangibles changed N/A year-over-year to $2.7 million; the TTM figure through Mar 2026 stood at $2.7 million (changed N/A YoY), while the FY2025 annual figure was $2.7 million, changed N/A from the prior year.
• Goodwill & Intangibles fell to $2.7 million in Q1 2026 per NRXP's latest filing, from $2.7 million in the prior quarter.
• Across five years, Goodwill & Intangibles topped out at $2.7 million in Q4 2025 and bottomed at $2.4 million in Q3 2025.